Peptide Comparison
PEG-MGFvsBPC-157
A supercharged version of your muscle's natural repair signal—PEGylated Mechano Growth Factor stays active for days instead of minutes, waking up dormant stem cells to rebuild and strengthen damaged muscle tissue.
The "Wolverine peptide" known for its remarkable healing properties across tendons, ligaments, muscles, and the gut.
At a Glance
Quick
comparison
Dose Range
PEG-MGF
100–200 mcg
BPC-157
250–500 mcg
Frequency
PEG-MGF
Twice weekly
BPC-157
Once daily
Administration
PEG-MGF
Subcutaneous injection
BPC-157
Subcutaneous injection
Cycle Length
PEG-MGF
4-6 weeks
BPC-157
4-6 weeks
Onset Speed
PEG-MGF
Moderate (1-2 weeks)
BPC-157
Moderate (1-2 weeks)
Evidence Level
PEG-MGF
Strong preclinical (extensive animal studies)
BPC-157
Strong preclinical (extensive animal studies)
Efficacy
Benefit
ratings
Muscle Recovery
Stem Cell Activation
Tissue Healing
Primary Benefit
Secondary Benefit
Additional Benefit
Technical Data
Compound
specifications
PEG-MGF
Molecular Formula
C121H200N42O39 (peptide core)
Molecular Weight
2867.2 g/mol (peptide) + PEG moiety
Half-Life
48-72 hours (vs. minutes for unmodified MGF)
Bioavailability
High when injected subcutaneously or intramuscularly; PEGylation protects from rapid degradation
CAS Number
108174-48-7
BPC-157
Molecular Formula
C62H98N16O22
Molecular Weight
1419.53 g/mol
Half-Life
4-6 hours
Bioavailability
~100% (subcutaneous)
CAS Number
137525-51-0
Protocols
Dosing
tiers
PEG-MGF
BPC-157
Applications
Best
suited for
PEG-MGF
Athletes Recovering from Muscle Injuries
If you've pulled, strained, or torn a muscle, PEG-MGF could be a game-changer. It activates the satellite cells (muscle stem cells) that your body uses to repair damaged fibers, potentially speeding up your return to training.
Serious Lifters and Bodybuilders
Heavy training creates microdamage in your muscles—that's actually how they grow. PEG-MGF amplifies your body's repair response, potentially helping you recover faster between sessions and make more gains from each workout.
Older Adults Concerned About Muscle Loss
As we age, our muscles become less responsive to the 'repair and grow' signals. Research shows older adults don't produce as much MGF after exercise. Supplementing with PEG-MGF might help restore some of that youthful repair capacity.
Post-Surgical Recovery (Under Medical Supervision)
If you're recovering from surgery involving muscle tissue, PEG-MGF's ability to recruit stem cells and promote tissue repair could support faster healing. Always use under medical guidance in these situations.
BPC-157
Tendon and ligament injuries
Sprains, strains, tears, tendinitis - BPC-157 accelerates collagen synthesis and tissue repair
Gut healing
IBS, leaky gut, ulcers, inflammatory bowel conditions - derived from gastric juice, it has a natural affinity for digestive tissue
Muscle injuries
Strains, post-workout recovery, chronic muscle issues - promotes angiogenesis and growth factor expression
Joint problems
Arthritis support, joint pain, cartilage issues - anti-inflammatory and regenerative properties
Post-surgical recovery
Accelerating healing after procedures - works systemically to enhance the body's repair mechanisms
Safety Profile
Side
effects
PEG-MGF
Common
- Injection site irritation
- Mild headache
- Temporary fatigue
Uncommon
- Localized swelling
- Blood sugar fluctuations
Serious
- Allergic reaction
BPC-157
Common
- Injection site redness
- Mild nausea
- Dizziness
Uncommon
- Headache
- Fatigue
- Hot/cold sensations
Serious
- Allergic reaction
Research Status
Safety
& evidence
PEG-MGF
Evidence Level
Strong preclinical (extensive animal studies)
FDA Status
Research compound
Safety Overview
PEG-MGF (pegylated mechano growth factor) demonstrates good tolerability in preclinical studies with minimal immunogenicity from pegylation modifications. Intramuscular administration shows local tissue responses consistent with growth factor activity. No serious systemic adverse events in animal models at therapeutic doses. Pegylation extends half-life from 2 hours (native IGF-1 Ec) to 24+ hours, reducing injection frequency while maintaining safety profile similar to parent peptide.
Contraindications
- xActive cancer or history of cancer
- xPregnancy or breastfeeding
- xKnown allergy to peptide components or PEG
- xChildren and adolescents
- xUncontrolled diabetes
BPC-157
Evidence Level
Strong preclinical (extensive animal studies)
FDA Status
Research compound
Safety Overview
BPC-157 is a gastric pentadecapeptide with strong preclinical evidence from extensive animal studies spanning over 25 years of research. Critical limitation: BPC-157 has NOT completed Phase 3 human clinical trials. No FDA approval exists. Safety data comes primarily from rat and mouse studies, with only limited Phase 1-2 human data. Animal studies show no toxicity at therapeutic doses, but human data is insufficient for regulatory approval. The peptide is unregulated, and no standardized manufacturing or quality control requirements exist for research compounds. Individual responses may vary significantly, and serious medical supervision is essential before use, particularly if you have gastrointestinal conditions, take medications, or have pre-existing medical conditions.
Contraindications
- xPregnancy
- xBreastfeeding
- xActive cancer
- xHistory of cancer
Decision Guide
Which is
right for you?
Choose PEG-MGF if...
- Muscle injury recovery
- Post-workout muscle repair
- Combating muscle wasting
- Supporting bone healing
Choose BPC-157 if...
- Injury recovery
- Post-surgery healing
- Chronic pain management
- Gut health